Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anirban Basu

Showing results (131-140 of 471) with videos related to

Pageof 48
Sort By:
Statistics in Medicine|October 13, 2005
Estimating transitions between symptom severity states over time in schizophrenia: a Bayesian meta-analytic approachAnirban Basu, Herbert Y Meltzer, Vanja Dukic
Pharmacoeconomics - Open|February 11, 2023
A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of AmericaAaron Winn, Anirban Basu, Scott D Ramsey
Health Economics|August 24, 2004
Comparing alternative models: log vs Cox proportional hazard?Anirban Basu, Willard G Manning, John Mullahy
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Financing a Cure for Diabetes in a Multipayer EnvironmentAnirban Basu, Prasun Subedi, Sachin Kamal-Bahl
Health Services & Outcomes Research Methodology|December 27, 2011
ESTIMATING TREATMENT EFFECTS ON HEALTHCARE COSTS UNDER EXOGENEITY: IS THERE A 'MAGIC BULLET'?Anirban Basu, Daniel Polsky, Willard G Manning
Journal of Neuroscience Research|December 21, 2011
Epigenetic regulation of self-renewal and fate determination in neural stem cellsIqbal Mohamed Ariff, Arinjay Mitra, Anirban Basu
Pharmacoeconomics|July 5, 2019
Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013Elizabeth D Brouwer, Anirban Basu, Kai Yeung
Physical Review Letters|February 9, 2005
A curious truncation of N=4 supersymmetric Yang-Mills theoryAnirban Basu, Michael B Green, Savdeep Sethi
Plos One|March 26, 2013
Binding of the 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs to tRNA(phe.)Anirban Basu, Parasuraman Jaisankar, Gopinatha Suresh Kumar
Health Services Research|December 17, 2009
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expendituresAnirban Basu, Wesley Yin, G Caleb Alexander
Pageof 48

Showing results (131-140 of 471) with videos related to

Sort By:
Pageof 48
Statistics in Medicine|October 13, 2005
Estimating transitions between symptom severity states over time in schizophrenia: a Bayesian meta-analytic approachAnirban Basu, Herbert Y Meltzer, Vanja Dukic
Pharmacoeconomics - Open|February 11, 2023
A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of AmericaAaron Winn, Anirban Basu, Scott D Ramsey
Health Economics|August 24, 2004
Comparing alternative models: log vs Cox proportional hazard?Anirban Basu, Willard G Manning, John Mullahy
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Financing a Cure for Diabetes in a Multipayer EnvironmentAnirban Basu, Prasun Subedi, Sachin Kamal-Bahl
Health Services & Outcomes Research Methodology|December 27, 2011
ESTIMATING TREATMENT EFFECTS ON HEALTHCARE COSTS UNDER EXOGENEITY: IS THERE A 'MAGIC BULLET'?Anirban Basu, Daniel Polsky, Willard G Manning
Journal of Neuroscience Research|December 21, 2011
Epigenetic regulation of self-renewal and fate determination in neural stem cellsIqbal Mohamed Ariff, Arinjay Mitra, Anirban Basu
Pharmacoeconomics|July 5, 2019
Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013Elizabeth D Brouwer, Anirban Basu, Kai Yeung
Physical Review Letters|February 9, 2005
A curious truncation of N=4 supersymmetric Yang-Mills theoryAnirban Basu, Michael B Green, Savdeep Sethi
Plos One|March 26, 2013
Binding of the 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs to tRNA(phe.)Anirban Basu, Parasuraman Jaisankar, Gopinatha Suresh Kumar
Health Services Research|December 17, 2009
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expendituresAnirban Basu, Wesley Yin, G Caleb Alexander
Pageof 48